MedTrace Logo

Reduction of Falls in the Elderly - Parkinson's Disease

NCT00518648 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2010-11-23

No results posted yet for this study

Summary

The REFINE-PD study is a controlled trial embedded within a larger cluster controlled study (the IMPACT study). The study aims to investigate the efficacy of a multifactorial falls prevention program for patients with Parkinson's Disease (PD). This program contains PD-specific elements (e.g., optimizing dopaminergic therapy), plus a generic falls prevention program. The intervention will be tailored to each individual's specific risk profile for falls, as identified during detailed baseline examination.

Conditions

Interventions

OTHER

Multifactorial fall prevention program

Individualised multifactorial fall prevention program containing PD-specific elements as well as generic elements

OTHER

Usual care

Usual care

Sponsors & Collaborators

  • National Parkinson Foundation

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Marten Munneke, PhD · UMC St. Radboud

  • Bastiaan R. Bloem, MD, PhD · UMC St. Radboud

  • Marjolein A. van der Marck, MSc · UMC St. Radboud

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00518648 on ClinicalTrials.gov